Tema Heart & Health ETF (HRTS)
36.50
+0.02
(+0.07%)
USD |
NASDAQ |
Jan 23, 14:20
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.75% | -0.14% | 58.08M | 7431.37 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.19% | 85.00% | -22.94M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term growth of capital by investing at least 80% of its net assets, in companies that derive at least 50% of revenues from products or services related to GLP-1 and treatment of cardiovascular diseases and/or metabolic diseases defined by Centers for Diseases Control and Preventions. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Tema |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 23, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.40% |
| Stock | 99.15% |
| Bond | 0.36% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.09% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term growth of capital by investing at least 80% of its net assets, in companies that derive at least 50% of revenues from products or services related to GLP-1 and treatment of cardiovascular diseases and/or metabolic diseases defined by Centers for Diseases Control and Preventions. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Tema |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |